Enasidenib plus azacitidine versus azacitidine alone in patients with newly diagnosed, mutant-IDH2 acute myeloid leukaemia (AG221-AML-005): a single-arm, phase 1b and randomised, phase 2 trial
Titel:
Enasidenib plus azacitidine versus azacitidine alone in patients with newly diagnosed, mutant-IDH2 acute myeloid leukaemia (AG221-AML-005): a single-arm, phase 1b and randomised, phase 2 trial
Auteur:
DiNardo, Courtney D Schuh, Andre C Stein, Eytan M Montesinos, Pau Wei, Andrew H de Botton, Stéphane Zeidan, Amer M Fathi, Amir T Kantarjian, Hagop M Bennett, John M Frattini, Mark G Martin-Regueira, Patricia Lersch, Frederik Gong, Jing Hasan, Maroof Vyas, Paresh Döhner, Hartmut